Develop New Product Candidate For Vulvar Lichen Sclerosus
Jan 18 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS BROADENS PIPELINE WITH NEW PRODUCT CANDIDATE FOR
VULVAR
LICHEN SCLEROSUS (VLS)
* HAS ENTERED INTO A PARTNERSHIP WITH AFT PHARMACEUTICALS
(AFT) TO
DEVELOP A NOVEL MUCOADHESIVE FILM FOR TREATMENT OF VULVAR LICHEN
SCLEROSUS
Source text for Eikon: ID:nGNE6kdq63
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV